… To explore whether SHP2 inhibition could suppress MEKi adaptive resistance, we
performed in vitro viability (PrestoBlue) and colony formation assays on a panel of KRAS-mutant …

… ERK signaling and the SHP2 phosphatase prevents adaptive resistance in defined subsets
… , p(Y542)SHP2 induction was observed in response to ERK signaling inhibition. The strategy …

… and functions of SHP2, and briefly review the development of SHP2 inhibitors. Importantly, …
to overcome drug resistance and synergistic tumor immunotherapy using SHP2 inhibitors. We …

… , SHP2 … SHP2, during adaptive resistance to MEKis, impaired the interaction with KSR1,
activating KSR1 to promote MAPK signaling. In conclusion, SHP2 promotes adaptive resistance …

… SHP2 blockade by SHP099 in combination with sorafenib attenuated the adaptive resistance
… Our results suggest that SHP2 inhibition could be a potential strategy to override sorafenib …

… To date, eight SHP2 inhibitors have advanced into clinical trials as … adaptive resistant
cancers. In this Perspective, we briefly summarize the strategies targeting SHP2 including inhibitors…

… Fedele and colleagues demonstrate that SHP2 inhibitors prevent adaptive MEK inhibitor
resistance; therefore, combining MEK and SHP2 inhibitors represents an exciting new …

… Here, by using two new affinity reagents that allow direct monitoring of KRAS G12C
activation and inhibition, we find that G12C-Is evoke adaptive resistance in vitro and in vivo by …

… have shown promise in overcoming resistance to kinase inhibitors … SHP2 inhibitors are
used to overcome drug resistance, especially to immunotherapy agents. Many SHP2 inhibitors …

… inhibitors, SHP2 inhibitors, and MEK/ERK inhibitors were assessed in combination with KRAS
G12C inhibitors … suggest that SHP2 inhibition can abrogate adaptive feedback reactivation …